Clinical Trials Browser

Interventional × Advanced Cancer × cemiplimab × Clear all

NCT02383212 2020-01-27

Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies

Phase 1 Completed

Advanced Cancer